Table 1.

Patient characteristics and clinical assessments of total study population and subgroups according to tender point classes. All values are median (10th to 90th percentile), unless otherwise indicated.

CharacteristicTotal, n = 196 (100%)TPC 0, n = 84 (43%)TPC 1–5, n = 60 (30%)TPC 6–10, n = 23 (12%)TPC ≥ 11, n = 29 (15%)p*
Age, yrs59 (40–78)58 (37–76)58 (42–76)60 (43–83)61 (43–79)NS
Female, %7078739183< 0.005
Disease duration, yrs4 (1–8)4 (1–8)2 (1–8)5 (1–9)5 (1–8)NS
RF-positive, %6666706166NS
EMS5 (0–90)0 (0–30)15 (0–60)20 (0–120)18 (0–285)< 0.00001
VAS pain14 (0–66)5 (0–50)12 (0–68)36 (8–84)33 (3–79)< 0.00000
HAQ1 (0–2)0.5 (0–1.6)1.0 (0.1–2.2)1.6 (1.1–2.3)1.5 (0.2–2.4)< 0.00000
TPC1 (0–13)0 (0–0)2 (1–5)8 (6–10)16 (12–18)NA
DAS283.1 (1.3–5.1)2.6 (1.2–4.7)3.3 (1.5–5.1)**3.4 (1.9–5.1)**4.1 (2.3–5.8)**< 0.001
  TJC1 (0–10)0 (0–5)2 (0–7)2 (0–17)5 (0–19)< 0.0001
  SJC1 (0–7)1 (0–8)1 (0–7)1 (0–11)1 (0–8)NS
  ESR, mm/h15 (4–41)12 (3–42)19 (4–49)19 (2–36)15 (5–42)NS
  VAS-GH, mm26 (1–67)18 (0–60)29 (3–70)34 (9–79)42 (10–70)< 0.01
  • * Kruskal-Wallis test.

  • ** All statistically significantly higher compared to DAS28 in group with TPC = 0 (Mann-Whitney U tests); corresponding means (SD) of DAS28 respectively 2.9 (1.4), 3.3 (1.3), 3.6 (1.6), and 4.0 (1.2); p < 0.0004 in ANOVA. RF: rheumatoid factor; EMS: early morning stiffness (0–180 min); VAS pain: visual analog scale for pain (0–100; 0 = no pain); HAQ: Health Assessment Questionnaire (0–3; 0 = no disability); TPC: tender point count (0–18); DAS28: Disease Activity Score; TJC: tender joint count (0–28); SJC: swollen joint count (0–28); ESR: erythrocyte sedimentation rate (0–140 mm/h); VAS-GH: VAS for general health (0–100 mm, 100 = worst score); NS: not statistically significant; NA: not applicable.